Long Term Follow-up of Pegylated-Interferon Alpha-2b

Status Completed

Clinical Trial Summary

The aim of this study was to investigate the long term outcome of Peginterferon alpha-2b with or without the addition of lamivudine in patients with chronic hepatitis B

Clinical Trial Description

Interferon alpha therapy is a generally accepted agent for the treatment of chronic HBV infection and effective in about one third of patients. Recently, in the HBV 99-01 study, pegylated interferon alpha-2b (PEG-IFN) has been shown to be effective in HBeAg-positive patients with chronic hepatitis B. In this study, 266 patients were randomized to receive PEG-IFN in combination with either lamivudine or placebo for 52 weeks.

Thirty-six percent of patients receiving monotherapy and thirty-five percent receiving combination therapy had lost serum HBeAg at the end of the 26 week post-treatment follow-up period and there was no difference between treatment groups (P = 0.91). More patients on combination therapy initially seroconverted (44% of patients, compared with 29% on monotherapy; P = 0.01) at the end of treatment but relapsed during follow-up. Similar response patterns were seen when response was assessed by DNA suppression and change in ALT levels.

In contrast to nucleoside analogues, such as lamivudine and adefovir dipivoxil, the virological and biochemical response to standard alpha-interferon has been shown to be durable after treatment discontinuation.In addition, standard alpha-interferon leads to improved survival and reduction of hepatocellular carcinoma in chronic hepatitis B patients.Pegylated interferons have shown to be effective in HBeAg-positive chronic hepatitis B patients, but the durability of the response and long-term outcome of treatment have yet to be established. ;

Study Design

Observational Model: Defined Population, Time Perspective: Longitudinal

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00146705
Study type	Observational
Source	Foundation for Liver Research
Contact
Status	Completed
Phase	N/A
Start date	May 2005
Completion date	September 2006

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04496882` - Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue	Phase 4
Completed	`NCT04083716` - A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults	Phase 1
Not yet recruiting	`NCT03038802` - A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection	Phase 1/Phase 2
Completed	`NCT05310487` - Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult Subjects	Phase 1
Recruiting	`NCT06070051` - Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy	Phase 1
Terminated	`NCT05001022` - A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB Subjects	Phase 1
Recruiting	`NCT04139850` - The Establishment of Korean Hepatitis B Patients Cohort
Recruiting	`NCT05343481` - Efficacy of VTP-300 in Chronic Hepatitis B Infection	Phase 2
Not yet recruiting	`NCT05490836` - Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients	N/A
Recruiting	`NCT04543565` - Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 Study	Phase 3
Active, not recruiting	`NCT02894918` - A Study to Evaluate Addition of Peginterferon Alfa-2a to Chronic Hepatitis B (CHB) Patients Treated With NAs	Phase 4
Not yet recruiting	`NCT02793791` - Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients	N/A
Recruiting	`NCT02287857` - Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B	N/A
Recruiting	`NCT01965418` - A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial	Phase 4
Recruiting	`NCT01491295` - Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients	Phase 4
Terminated	`NCT01872988` - Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma	Phase 3
Recruiting	`NCT01487876` - Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients	Phase 2
Completed	`NCT01531166` - A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon	N/A
Not yet recruiting	`NCT01436539` - Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients	Phase 4
Recruiting	`NCT01360879` - Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease	N/A